Tomoki Abe Selected Research

Tomoki Abe Research Topics

Disease

9	Muscular Atrophy (Muscle Atrophy) 06/2022 - 02/2009
8	Neoplasms (Cancer) 12/2022 - 01/2015
8	Atrophy 12/2019 - 12/2012
5	Esophageal Squamous Cell Carcinoma 10/2022 - 01/2022
4	Obesity 05/2023 - 06/2013
4	Inflammation (Inflammations) 12/2022 - 01/2013
4	Lymphoma (Lymphomas) 06/2022 - 12/2012
3	Insulin Resistance 12/2022 - 01/2014
3	Muscular Diseases (Myopathy) 12/2022 - 05/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2015
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2019
2	Starvation 12/2019 - 05/2015
2	Body Weight (Weight, Body) 11/2019 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 01/2015 - 01/2015
2	Hypoxia (Hypoxemia) 01/2015 - 01/2015
1	Muscle Weakness 12/2022
1	Hypertrophy 12/2022
1	Lymphatic Metastasis 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Nausea 01/2021
1	Vomiting 01/2021
1	Dyslipidemias (Dyslipidemia) 10/2020
1	Neoplasms, Cystic, Mucinous, and Serous 04/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Acute Cholecystitis 02/2019
1	Breast Neoplasms (Breast Cancer) 02/2019
1	Ductal Carcinoma 02/2019
1	Chronic Disease (Chronic Diseases) 05/2015
1	Disease Progression 01/2015

Drug/Important Bio-Agent (IBA)

9	Ligases (Synthetase)IBA 11/2019 - 02/2009
9	UbiquitinIBA 11/2019 - 02/2009
4	AlbuminsIBA 10/2022 - 04/2022
3	CytokinesIBA 12/2022 - 01/2013
3	Triglycerides (Triacylglycerol)IBA 12/2022 - 01/2022
3	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 04/2020
3	Insulin-Like Growth Factor I (IGF-1)IBA 12/2019 - 12/2012
2	Messenger RNA (mRNA)IBA 12/2022 - 06/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2022 - 01/2016
2	DystrophinIBA 12/2022 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2022 - 01/2021
2	LipidsIBA 11/2019 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 05/2015 - 01/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2015 - 01/2015
2	Angiogenesis InhibitorsIBA 01/2015 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 01/2015
1	nobiletinIBA 05/2023
1	sudachitinIBA 05/2023
1	Sucrose (Saccharose)IBA 12/2022
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 12/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2022
1	branched-chain-amino-acid transaminaseIBA 06/2022
1	TroponinIBA 06/2022
1	higenamine (norcoclaurine)IBA 06/2022
1	F-Box ProteinsIBA 06/2022
1	AntiemeticsIBA 01/2021
1	Palonosetron (Aloxi)FDA Link 01/2021
1	Aprepitant (Emend)FDA Link 01/2021
1	Olanzapine (Zyprexa)FDA Link 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021
1	Fish OilsIBA 10/2020
1	FructoseIBA 10/2020
1	Uric Acid (Urate)IBA 10/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020
1	CarbohydratesIBA 12/2019
1	Muscle Proteins (Muscle Protein)IBA 12/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2019
1	Estrogen ReceptorsIBA 02/2019
1	pyruvate dehydrogenase kinase 4IBA 01/2016
1	Uncoupling Protein 3IBA 01/2016
1	Starch (Cornstarch)IBA 05/2015
1	OligopeptidesIBA 05/2015
1	AgarIBA 05/2015
1	Toll-Like Receptor 2IBA 05/2015
1	atelocollagenIBA 05/2015
1	GlucocorticoidsIBA 03/2015
1	GSK 1363089IBA 01/2015
1	Soybean Proteins (Soy Protein)IBA 01/2015
1	FlavonesIBA 01/2015
1	ApigeninIBA 01/2015
1	LuteolinIBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	FlavonoidsIBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Vascular Endothelial Growth Factor BIBA 01/2015
1	regorafenibIBA 01/2015

Therapy/Procedure

3	Ketogenic Diet 12/2022 - 12/2019
3	Therapeutics 01/2021 - 01/2015
2	Neoadjuvant Therapy 10/2022 - 10/2022
2	Drug Therapy (Chemotherapy) 01/2021 - 02/2019
2	Bed Rest (Bedrest) 12/2012 - 12/2012
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2022
1	Kampo Medicine (Kampo) 06/2022
1	Esophagectomy 01/2022
1	Segmental Mastectomy (Lumpectomy) 01/2020
1	Hepatectomy 01/2020
1	Laparoscopic Cholecystectomy 02/2019